🇩🇪 Germany · EU Public Tender
IIT study CLEAR "Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)"
🏛️ Universitätsklinikum Münster · 📍 Münster
—
Estimated value
21 November 2024
Deadline
| Contract type | Services |
| CPV | 71335000 |
| Deadline | 21 November 2024 |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.